baber/WOPTO huggingface dataset:
Patent CA-2727197-A1 (CA)
Inventor: STUCHLIK MILAN
IPC: A23L33/105
Filed: 2009-06-22
Abstract: The invention relates to a composition containing flavanolignans, e.g., isolated from Silybum marianum, and basic amino acids and, optionally, other auxiliary substances, in the form of mixture, and to the method of preparation of these composi-tions by mixing the components and their homogenization. The invention is applicable particularly in the pharmaceutical industry, cosmetics, food industry, breweries, distilleries, and in the industry of beverage production. Formula (I)
Patent CA-2727247-A1 (CA)
Inventor: LENZ HEINZ-JOSEF
IPC: C12Q1/68
Filed: 2008-06-10
Abstract: The invention provides compositions and methods for determining the likelihood of tumor recurrence following treatment with 5-FU based adjuvant therapy for Stage II or Stage III colon cancer patients. After determining if a patient is less likely to experience tumor recurrence once treated, the invention also provides methods for treating these patients.
Patent CA-2728480-A1 (CA)
Inventor: GALLEY GUIDO
IPC: C07D263/28
Filed: 2009-07-15
Abstract: The invention relates to compounds of formula (I) wherein R1 is hydrogen, lower alkyl, lower alkoxy, lower alkyl substituted by halogen, lower alkoxy substituted by halogen, halogen, cyano, nitro, hydroxy, C(O)O-lower alkyl, S(O)2-lower alkyl, C(O)OCH2-phenyl, OCH2-phenyl, tetrazol-1-yl, phenyl optionally substituted by halogen, or is phenyloxy optionally substituted by halogen, or is benzyl optionally substituted by halogen or is benzyloxy optionally substituted by halogen, wherein the substituents for n > 1 may be the same or different; X is -O-(CH2)2-, -O-CHR"-CH2-, -O-CH2-CHR', -O-CR"2-CH2-, -(CH2)2-CHR', -CHR'-(CH2)2-, -CR"2-(CH2)2-, -CH2-CHR'-CH2-, -CH2-CR"2-CH2-, -CHR"-O-CH2-, -CH2-O-CH2-, -CR"2-O-CH2-, -CF2(CH2)2-, --CR"2-CH2-, -SiR"2-(CH2)2-, -S-(CH2)2-, -S(O)2-(CH2)2-, -(CH2)4-, -CH2-O-(CH2)2-, for m being 0, 1, 2 or 3; R' is lower alkyl, lower alkoxy or lower alkyl substituted by halogen; R" is lower alkyl or lower alkyl substituted by halogen; R2 is hydrogen or lower alkyl; Y is aryl, cycloalkyl or heteroaryl; n is 1, 2 or 3; or to a pharmaceutically suitable acid addition salt. The compounds disclosed in the present formula (I) may be used for the treatment of diseases related to the biological function of the trace amine associated receptors, which diseases are depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder, stress- related disorders, psychotic disorders, schizophrenia, neurological diseases, Parkinson's disease, neurodegenerative disorders, Alzheimer's disease, epilepsy, migraine, substance abuse and metabolic disorders, eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.
Patent CA-2733355-A1 (CA)
Title: Method for the decomposition of n2o, catalyst for it, and the preparation of this catalyst
Inventor: PIETERSE JOHANNIS ALOUISIUS ZACHARIAS
IPC: B01J29/76
Filed: 2009-07-10
Abstract: The invention relates to a method for the catalytic decomposition of N2O in an N2O- and NO x-containing gas in the presence of a catalyst, wherein the catalyst contains a zeolite that has been loaded with a first metal chosen from a group of noble metals consisting of ruthenium, rhodium, palladium, silver, rhenium, osmium, iridium, platinum and gold, and with a second metal chosen from a group of transition metals consisting of chromium, manganese, iron, cobalt, nickel and copper, and in that the loading of the zeolite with these metals is effected by loading the zeolite with the noble metal and the transition metal simultaneously, also relating to a catalyst for this method and to a method for the preparation of said catalyst.
Patent CA-2735177-A1 (CA)
Inventor: BRANCA DANILA
IPC: C07D487/04
Filed: 2009-08-28
Abstract: The present invention relates to compounds of formula I: and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of the Sonic Hedgehog pathway, in particular Smoantagonists. Thus the compounds of this invention are useful for the treatment of diseases associated with abnormal hedgehog pathway activation, including cancer, for example basal cell carcinoma, medulloblastoma, prostate, pancreatic, breast, colon, bone and small cell lung cancers, and cancers of the upper GI  tract.
Patent CA-2737887-A1 (CA)
Title: A method and arrangement for determining a minimum transmit power gain factor for an enhanced uplink data communication
Inventor: LIU JINHUA
IPC: H04W52/04
Filed: 2009-06-05
Abstract: A method and arrangement are provided for determining a minimum value or range for a transmit power gain factor an enhanced uplink data channel, referred to as .beta.ed; min, that controls the transmit power level for the enhanced uplink data channel relative to the transmit power for the uplink control channel so as to ensure delivery of a minimum data service requirement over the enhanced uplink data channel. The minimum value or range for the enhanced uplink data channel power gain factor may be determined based on a selected enhanced uplink transmission format and/or a maximum number of allowable transmission attempts over the enhanced uplink data channel for a communications session so that the required Quality of Service (QoS) for the communications session can be fulfilled and an expected uplink coverage gain can be reached.  The minimum value or range for the enhanced uplink data channel power gain factor is also compatible with other techniques to increase enhanced uplink coverage such as autonomous retransmission and improved L2 techniques.
Patent CA-2737972-A1 (CA)
Title: Aseptically packaged nutritional concentrate
Inventor: ULSTAD DAVID C
IPC: A23C3/00
Filed: 2011-04-26
Abstract: Disclosed are packaged compositions comprising an aseptically sterilized container and a sterilized, concentrated nutritional emulsion that is aseptically packaged and sealed within the container. Also disclose are methods for making and using the packaged compositions. In some embodiments, the aseptically packaged, concentrated nutritional emulsions have a desirable flavor and aroma and have increased emulsion stability.
Patent CA-2739436-A1 (CA)
Inventor: FORBES WILLIAM
IPC: A01N43/42
Filed: 2009-10-02
Abstract: The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.
Patent CA-2739851-A1 (CA)
Inventor: FORSELL PETER
IPC: A61B17/12
Filed: 2008-10-10
Abstract: An apparatus for controlling a flow of sperms in a uterine tube formed by a uterine tube wall of a patient's uterine tube comprises an implantable constriction device for gently constricting (ie. without substantially hampering the blood circulation in the uterine tube wall) at least one portion of the uterine tube wall to influence the flow in the uterine tube, and a stimulation device for stimulating the wall portion of the uterine tube wall. A control device controls the stimulation device to stimulate the wall portion, as the constriction device constricts the wall portion, to cause contraction of the wall portion constricted by the constriction device to further influence the flow in the uterine tube. The apparatus can be used for restricting or stopping the flow in the uterine tube, or for actively moving the fluid in the uterine tube, with a low risk of injuring the uterine tube.
Patent CA-2740275-A1 (CA)
Inventor: PHILLIPS DAVID ANTHONY
IPC: H01R24/40
Filed: 2011-05-12
Abstract: A contact assembly that comprises an outer body and an insert assembly receivable in the outer body. The insert assembly includes a housing and a conductive barrier received in the housing. The conductive barrier defines first and second receiving areas in the housing. At least a first contact member is receivable in the first receiving area and at least a second contact member is receivable in the second receiving area. Each of the first and second contact members is adapted to accept a conductor.
Patent CA-2740729-A1 (CA)
Title: Dispositif depilatoire de distribution de liquide
Inventor: HAWES CHRISTOPHER MARTIN
IPC: A45D26/00
Filed: 2009-10-15
Abstract: Linvention concerne un dispositif dépilatoire (1) comprenant un manche (2) et un réservoir compressible (3) approprié pour contenir un liquide à distribuer pendant lutilisation du dispositif dépilatoire, le dispositif dépilatoire comprenant en outre un récipient (4) renfermant le réservoir compressible, une sortie de liquide (5) conçue pour permettre la sortie du liquide à la fois du réservoir compressible et du récipient, un orifice (6) conçu pour permettre lécoulement de lair dans ou hors du récipient, et un dispositif daspiration (7) conçu pour aspirer le liquide hors du réservoir compressible à travers la sortie de liquide. Le récipient peut être rigide, rigide déformable ou une combinaison des deux.
Patent CA-2742034-A1 (CA)
Inventor: JIN LUOJUN
IPC: H04L12/16
Filed: 2011-05-30
Abstract: A system, device and method for service insertion during a video display. A  client device detects a video request input, and in response, selects and initiates an advanced service asset while the player buffers the requested video data. The output of the player is displayed in a background field while the media display data of the advanced service asset is displayed in a foreground field. The player display data may be brought to the foreground after a preset time or when the player is ready to display the requested video.
Patent CA-2743313-A1 (CA)
Inventor: OGURA KYOICHI
IPC: A61P9/12
Filed: 2004-03-17
Abstract: It is intended to provide ACE inhibitory tripeptides which are not easily digested by digestive enzymes after being orally taken and thus have fewer tendencies to lose their ACE inhibitory activity in vivo.     More specifically, 3 tripeptides having an ACE  inhibitory activity and showing a hypotensive effect in an animal experiment are discovered from a thermolysin digestion product of sesame. These tripeptides respectively have amino acid sequences Leu-Ser-Ala, Val--Ile-Tyr and Leu-Val-Tyr and show an angiotensin converting enzyme inhibitory activity.
Patent CA-2749139-A1 (CA)
Inventor: TODARY MICHAEL FAYEK F
IPC: A61J7/00
Filed: 2011-08-10
Abstract: The present document describes a mobile pharmacy comprising: motorized vehicle; Pharmacist, pharmacy Technician, an inventory of healthcare products; a computer system connected to the internet. There is also described the use of a mobile pharmacy to provide pharmacist counseling to various remote areas where it reaches a specific sheltered place in the village to facilitate providing the pharmaceutical and health services to village population.
Patent CA-2754451-A1 (CA)
Inventor: GILL MANJIT SINGH
IPC: G06F3/14
Filed: 2010-02-17
Abstract: A portable computing device (PCD) dock-ing station is disclosed and may include an upper housing portion, a lower housing portion hingedly connected to the upper housing portion, and a PCD engagement mech-anism formed in the lower housing portion, the upper housing portion, or a combination thereof, wherein the PCD engagement mechanism is configured to removably engage a PCD when the PCD is docked with the PCD  docking station. Further, the portable computing device may include a wired dock connection formed in the lower housing portion, the upper housing portion, or a combina-tion thereof. The wired dock connection may be config-ured to provide connectivity between the PCD and the PCD docking station.
Patent CA-2755279-A1 (CA)
Title: Cured in place pipe liner with styrene barrier
Inventor: WIESSNER ROBERT J
IPC: B32B27/40
Filed: 2010-03-09
Abstract: A liner for repairing damaged pipes, such as underground sewer or gas pipes is disclosed. The liner comprises a TPU coating on fibrous mat of non-woven fabric. The TPU coating contains a barrier layer to retard the migration of styrene from the liner to the media used to force the liner against the damaged pipe and to activate the thermoset resin. The thermoset resin converts the liner from a flexible state to a rigid state as the liner is cured in place inside the pipe.
Patent CA-2755503-A1 (CA)
Inventor: BATES MICHAEL R
IPC: E03C1/232
Filed: 2010-03-31
Abstract: A sink assembly provides an enhanced overflow system for an under-counter mountable sink. The sink has an overflow cutout with an open top formed adjacent an upper rim of the basin of the sink. When the sink is mounted to the bottom surface of a counter top, the sink and counter together form an overflow opening, thereby permitting the overflow to be more easily concealed and increasing the fill capacity of the sink. Methods of installing such sink assemblies are also disclosed.
Patent CA-2759642-A1 (CA)
Inventor: ROY ALLEN
IPC: F01D5/14
Filed: 2011-11-22
Abstract: A method of making a leading edge component for an airfoil device having a shape substantially conforming to an airfoil includes providing a first elongate sheet having a shape substantially conforming to a surface on one of a suction side or a pressure side of the airfoil and comprising an elongate edge. A second elongate sheet can be provided that has a shape substantially conforming to a surface on the other of the suction side or the pressure side of the airfoil and comprising an elongate edge. The first elongate sheet and the second elongate sheet can be welded together at least along their respective elongate edges in such a way as to form a leading edge base structure comprising a weld and a convex outer surface, and the weld can extend along a length of the convex outer surface. A plurality of material deposits can be provided onto an outer surface of the leading edge base structure in such a way as to substantially cover the weld, whereby the leading edge component is formed.
Patent CA-2760711-A1 (CA)
Inventor: RICH DAVID GERARD
IPC: H05K7/20
Filed: 2011-12-06
Abstract: An electrical power source for a portable electronic device. The electrical power source includes at least one fuel cell adapted to receive fuel and generate therefrom electrical power for powering at least one component of the portable electronic device, a fuel tank adapted to provide fuel to the fuel cell, and at least one thermoelectric module in thermal contact with at least one of the fuel cell and fuel tank for regulating the temperature of the at least one fuel cell and at least one fuel tank.
Patent CA-2761468-A1 (CA)
Title: Modular staircase systems
Inventor: BROOKS HAROLD ALBERT
IPC: E04F11/02
Filed: 2011-12-09
Abstract: Modular staircases and staircase assemblies comprising components with notches that fit into and interweave with each other. Certain embodiments of modular staircases have at least two webs, wherein the perimeter of each web resembles a staircase with steps. The webs may be coupled together by a plurality of cross-beams. Each of the webs and the cross--beams may have notches that fit into and interweave with each other to form the basic structure of a staircase. The staircase may also be provided with cover pieces to cover the exposed webs and cross beams, and thus, to provide a surface for a user to sit or step on.  Embodiments described herein are modular, in that they may be coupled together in various configurations and thus coupled to straight walls, curved walls, or any combination thereof.  Additionally, embodiments described herein may be installed in either vinyl liner-type pools or concrete pools.
Patent CA-2761964-A1 (CA)
Inventor: AUDONNET JEAN-CHRISTOPHE
IPC: C12N15/73
Filed: 2010-05-24
Abstract: The present invention provides a method of maintaining a gram negative bacterium plasmid without the use of antibiotic selection pressure. Further, the invention relates to the drugless plasmids produced including drugless plasmids containing a heterologous gene. The invention also provides formulations and/or compositions comprising the drugless plasmids comprising a heterologous gene, formulations and/or compositions comprising a protein or an immunogen expressed using the drugless plasmids, and methods of administering such formulations and/or compositions to a host.  The invention relates to gram negative bacteria containing the drugless plasmids.
Patent CA-2762026-A1 (CA)
Title: A method and system for making a long distance call
Inventor: RUSH AARON
IPC: H04M3/38
Filed: 2011-12-09
Abstract: A method of long distance calling combines Voice Over Internet Protocol technology with either a PSTN or a POTS or a cellular device.  A call is placed from a first telephone to communicate with a server.  From the server, the call is streamed over the internet using Voice Over Internet Protocol technology to a second telephone, without requiring a long distance telephone carrier. Callers can use regular telephones to communicate between long distances by interjecting use of a server so as to avoid incurring long distance telephone charges. A system comprising software for communicating between two phone lines using a server, a server and at least one SIP number is also provided.
Patent CA-2764016-A1 (CA)
Inventor: SMITH WILLIAM G
IPC: C02F3/08
Filed: 2012-01-16
Abstract: Introducing a combination of high surface area growth media and biological reactants into a sewage treatment process with or without additional reaction to improve and increase capacity of a given process. The high surface area media and biological reactants can be dispersed at strategic locations in a new or existing attached growth wastewater treatment plant so as to provide additional sites for biological growth and improved wastewater renovation.
Patent CA-2764220-A1 (CA)
Title: Method of carrying out pyrolysis and pyrolysis apparatus
Inventor: JOKELA PEKKA
IPC: F23C10/00
Filed: 2010-06-01
Abstract: The invention relates to a method of carrying out pyrolysis process in a pyrolysis reactor (4) for solid fuel to produce pyrolysis oil. The method comprises supplying solid fuel into a drying zone in the pyrolysis reactor (4) for removing moisture containing gases, drying the solid fuel in the drying zone and extracting the moisture containing gases re- moved from the solid fuel out of the pyrolysis reactor (4), passing the dried solid fuel from the drying zone to the pyrolysis zone of the pyrolysis reactor (4), pyrolyzing the dried solid fuel for separating pyrolysis gases from the dried solid fuel and conducting the pyrolysis gases from the pyrolysis reactor (4) to a condenser (8) for producing pyrolysis oil.
Patent CA-2764446-A1 (CA)
Inventor: KASEKO GALINA
IPC: C12N5/16
Filed: 2010-06-10
Abstract: The present invention relates to hybrid cells and methods for producing hybrid cells. In particular, the invention relates to hybrid cells generated from the hybridization of at least three cells where at least two cells are derived from different lineages. The invention further relates to the use of hybrid cells for the expression of proteins useful in a range of diagnostic, prophylactic, therapeutic and/or research applications.
Patent CA-2767153-A1 (CA)
Title: Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
Inventor: WU CHENGDE
IPC: A61K31/55
Filed: 2004-02-18
Abstract: The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.
Patent CA-2770555-A1 (CA)
Title: Spontaneously contracting fish cell aggregates, use thereof and method for the production thereof
Inventor: KRUSE CHARLI
IPC: G01N33/50
Filed: 2010-09-08
Abstract: The invention relates to an in vitro method for producing spontaneously contracting fish cell aggregates, to the fish cell aggregates obtained thereby, and to the use thereof, in particular for testing biological active substances and pharmaceuticals. The in vitro method according to the invention for producing contracting fish cell aggregates comprises the following steps: a) mechanical comminution and/or partial enzymatic digestion of fish embryos or fish larvae; b) transfer of the comminuted and/or partially digested fish tissue into an enzyme-free medium and removing the supernatant by centrifuging to obtain a cell pellet; c) re-suspension of the cell pellet in a cell culture medium; d) culturing the cells, with the medium being changed at least once, until spontaneously contracting cell aggregates form.
Patent CA-2771424-A1 (CA)
Title: Renfort a meches de fils de verre paralleles
Inventor: CHOMARAT GILBERT
IPC: D04H1/14
Filed: 2010-08-11
Abstract: Le renfort selon l'invention comporte une couche de renfort (2) à base de mèches (2a) parallèles de fils de verre continus, et une ou deux couches de liaison (3) à tronçons de fibres à surface thermofusible. L'ensemble est solidarisé par des tronçons pénétrants (3b) de fibres à surface thermofusible, qui pénètrent selon une partie de leur longueur dans la couche de renfort (2) et qui adhèrent aux fils de verre continus des mèches (2a).
Patent CA-2772394-A1 (CA)
Inventor: AEBI VERLE W
IPC: H04N5/33
Filed: 2010-08-31
Abstract: A sensor for night vision applications is provided, wherein the sensor comprises a semiconductor absorption layer of composition that limits long wavelength response cutoff to between 1.25 to 1.4µm wavelength. The selection of this cutoff frequency provides improved dark current performance, thereby requiring less cooling of the sensor. Consequently, energy consumption is reduced, as the sensor does not require active cooling, so that the sensor is particularly beneficial for mobile night vision applications where battery weight is of high importance.
Patent CA-2772643-A1 (CA)
Inventor: YANG SHIAW-DER
IPC: C12Q1/48
Filed: 2010-09-01
Abstract: The present invention provides methods and compositions for identifying and detecting lethal cells useful for monitoring disease status and therapy response in various types of cancer patients regardless of the etiological origin of the cancer and uses thereof.
Patent CA-2774188-A1 (CA)
Title: Single absorber vessel to capture co2
Inventor: MURASKIN DAVID J
IPC: C01B32/50
Filed: 2010-09-01
Abstract: A method and system for removing CO2 from a flue gas stream containing CO2 is provided, the method including the steps of a) contacting a flow of a first ionic solution comprising NH3 with a flue gas stream to remove a first portion of CO2 from the flue gas stream, b) collecting the used ionic solution from step a) in a first sump vessel, c) recycling ionic solution from the first sump vessel to step a), d) contacting a flow of a second ionic solution comprising NH3 with the flue gas stream to remove a second portion of CO2 from the flue gas stream, e) collecting the used ionic solution from step d) in a second sump vessel, and f) recycling ionic solution from the second sump vessel to step d).
Patent CA-2775560-A1 (CA)
Inventor: SMITH DAVID
IPC: H04L12/24
Filed: 2012-04-27
Abstract: Systems and methods of performing incremental DNSSEC signing at a registry are described in which digital signature operations may be performed as part of a single transaction including DNS add, update, and/or delete operations and the like. Exemplary methods may include receiving a domain command from a requester, the domain command including an identifier of a domain. The received domain command may be executed with respect to data stored by the registry for the domain. As part of an individual transaction including the execution of the domain command, the registry may also sign DNSSEC records for the domain using a private key of an authoritative server. After the DNSSEC records have been signed, the registry may incrementally publish the signed DNSSEC records to a separate server. Exemplary methods may also include "look-aside" operations in which, for example, add, update, and/or delete operations may be executed on data stored in a registry database and reported to a requester, prior to applying digital-signatures to the DNSSEC data. After reporting that the instructions have been executed, the registry may generate a digital signature based on the add, update, and/or delete changes, and commit the digital signature to a registry resolution database.